- Our Team
- For Patients
- Treatments & Services
- Medical Professionals
Leukemia
Clinical Trial Search
Trial Protocol ID
USOR 18263_BGB-3111-215 *STAR*
A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients with Previously Treated B-Cell Lymphoma Intolerant of Prior Treatment with Ibrutinib and/or Acalabrutinib
Trial Protocol ID
AZA-MDS-006
Investigator
Mohit Narang, M.D.
Connect® Myeloid: The Myelofibrosis (MF), Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry